Catalog List

ProT2® MHC Class II Tetramers

Tetramers/Monomers by Research Area:

AllergyAspergillusAutoimmunity
Bordetella PertussisCancerCMV
COVID-19 / SARS-CoV-2EBVFactor VIII
HBVHCVHIV
HPVInfluenzaMalaria
Multiple SclerosisTetanusTherapeutic Antibodies
TuberculosisNegativeHelicobacter pylori
LCMVListeriaModel Antigens / Other
RSVWest Nile Virus

Search the table below by disease, allele, specificity or sequence, or any combination, e.g. “Cancer NY-ESO DRB1*04:01”. If your specificity is not listed, we can synthesize Custom MHC Class II Tetramers at no additional cost.

Research AreaAllelePeptide CodePeptide SequenceEpitope Origin
AllergyDRB1*01:013137DSVTPMILKAQKGGNLDog dander Can f 1 33-48
AllergyDRB1*01:013147KCIEWEKAQHGAMugwort pollen Art v 1 25-36
AllergyDRB1*01:013152LPVVLENARILKNCVDAKCat dander Fel d 1 53-70
AllergyDRB1*01:013153ALRQMRTVTPIRMQGGHouse dust mite Der p1 96-110
AllergyDRB1*01:013163AVAAAPQVKYAVFEAALTKAITimothy grass Phl p 5 p26
AllergyDRB1*01:012899YESYKFIPALEAAVKGrass pollen allergen Phl p 5 196-210
AllergyDRB1*01:012898AETLLRAVESYLLAHSBirch pollen allergen Bet v 1 142-156
AllergyDRB1*04:013131APYHFDLSGHAFGRye grass Lol p1 124-136
AllergyDRB1*04:013139ELEKYQQLNSERGVPNCow dander Bos d 2 143-158
AllergyDRB1*04:012898CETLLRAVESYLLAHSBirch pollen allergen Bet v 1 141-155
AllergyDRB1*04:013163BVAAAPQVKYAVFEAALTKAITimothy grass Phl p 5 p26
AllergyDRB1*07:013136DRVNFKYSFSVIEAlder pollen Aln g 1 76-88
AllergyDRB1*07:013163CVAAAPQVKYAVFEAALTKAITimothy grass Phl p 5 p26
AllergyDRB1*07:013164AVGLLKAVESYLLAAlder pollen Aln g 1 142-154
AllergyDRB1*09:013163DVAAAPQVKYAVFEAALTKAITimothy grass Phl p 5 p26
AllergyDRB1*11:013151LEAAFNAEFNEIRRVLLEENPeanut Ara h 1 321-340
AllergyDRB1*11:013161TSRNNPFYFPSRRFSTRYGNPeanut Ara h 1 169-188
AllergyDRB1*11:013165VVNKGTGNLELVAVRKEQQQPeanut Ara h 1 457-476
AllergyDRB1*11:013163EVAAAPQVKYAVFEAALTKAITimothy grass Phl p 5 p26
AllergyDRB1*15:013163FVAAAPQVKYAVFEAALTKAITimothy grass Phl p 5 p26
AllergyDRB1*15:013164BVGLLKAVESYLLAAlder pollen Aln g 1 142-154
AllergyDRB1*15:013134AVNIVGYSNAQGVDYHouse dust mite Der p1 251-265
AllergyDRB1*15:012898BETLLRAVESYLLAHSBirch pollen allergen Bet v 1 142-156
AllergyDRB1*15:013153BLRQMRTVTPIRMQGGHouse dust mite Der p1 96-110
AspergillusDRB1*03:013145HTYTIDWTKDAVTWSAspergillus fumigatus Crf1/p41 171-185
AspergillusDRB1*04:012858FHTYTIDWTKDAVTWAspergillus fumigatus Crf1/p41 170-184
AutoimmunityDRB1*03:012950SLQPLALEGSLQKRGInsulin Precursor 76-90
AutoimmunityDRB1*03:013043TVYGAFDPLLAVADGAD2 339-352
AutoimmunityDRB1*04:011941NFIRMVISNPAATGAD65 555-567
AutoimmunityDRB1*04:012701IAFTSEHSHFSLKGAD65 274-286
AutoimmunityDRB1*04:012734GAGSLQPLALEGSLQKRGProinsulin 73-90
AutoimmunityDRB1*04:012897GIVEQCCTSICSLYQProinsulin 90-104
AutoimmunityDRB1*04:012951SLQPLALEGSLQSRGPreproinsulin 76-90 88S
AutoimmunityDRB1*04:013132ATEG[cit]V[cit]VNSAYQDKCit aggregan 89-103
AutoimmunityDRB1*04:013133ATIKAEFV[cit]AETPYMCit CILP 297?311
AutoimmunityDRB1*04:013138DVMNILLQYVVKSFDRSTKVGAD65 113-132
AutoimmunityDRB1*04:013143GKLYGI[cit]DV[cit]STRDRCit CILP 982?996
AutoimmunityDRB1*04:013144GVYAT[cit]SSAV[cit]L[cit]SSVPGVRCit vimentin aa 59-78
AutoimmunityDRB1*04:013146IFDS[cit]GNPTVEVDLFCit alpha-enolase 11-25
AutoimmunityDRB1*04:013148KGMAALPRLIAFTSEHSHFSGAD65 265?284
AutoimmunityDRB1*04:013157QDFTN[cit]INKLKNSCit fibrinogen-alpha 79-91
AutoimmunityDRB1*15:011912DENPVVHFFKNIVTPRTPPMyelin basic protein 83-101
AutoimmunityH-2 IAb423NAGFNSNRANSSRSSDBY 608-622
AutoimmunityH-2 IAb3955GEPGIAGFKGEQGPKType II collagen (CII) 256-270
AutoimmunityH-2 IAg74273SPGDLQTLALEVARQKRGmouse ProInsulin 47-64
Bordetella PertussisDRB1*07:013167YYSNVTATRLLSSTNSPertussis toxin subunit 2 129-144
CancerDRB1*01:013092GWVKPIIIGHHAYGDQYRATisocitrate dehydrogenase [NADP] cytoplasmic (IDH1)(123-142)
CancerDRB1*01:012844KSVWSKLQSIGIRQHTERT UPC2 (578-592)
CancerDRB1*01:012733ACYEFLWGPRALVETSMAGE-A3 267-282
CancerDRB1*01:012712ALKEFTVSGNILTIRLNY-ESO-1 123-137
CancerDRB1*01:012736ALLEFYLAMPFATPMENY-ESO-1 87-101
CancerDRB1*01:012894AKVPIKWMALESILRRRFHER2 883-899
CancerDRB1*04:01479WNRQLYPEWTEAQRLDgp100 44-59
CancerDRB1*04:011945ISPNSVFSQWRVVCDSLEDYDTyrp1 277-297
CancerDRB1*04:012888ESEFQAALSRKVAKLMAGE-A6 102-116
CancerDRB1*04:012889LTQYFVQENYLEYRQVPGMAGE-A6 246-263
CancerDRB1*04:012890YACFVSNLATGRNNSCEA 653-667
CancerDRB1*04:012891NYTLRVDCTPLMYSLPSMA 459-473
CancerDRB1*04:012892IYRRRLMKQDFSVPQLPHSgp100 615-633
CancerDRB1*04:012893ALHIYMDGTMSQVQGSAtyrosinase 365-381
CancerDRB1*04:012895RNGYRALMDKSLHVGTQCALTRRMART-1 51-73
CancerDRB1*04:012712BLKEFTVSGNILTIRLNY-ESO-1 123-137
CancerDRB1*04:012736BLLEFYLAMPFATPMENY-ESO-1 87-101
CancerDRB1*04:012894BKVPIKWMALESILRRRFHER2 883-899
CancerDRB1*04:053215LWWVNNQSLPVSPCEA 321-333ÿ
CancerDRB1*09:012736CLLEFYLAMPFATPMENY-ESO-1 87-101
CancerDRB1*11:012887TSYVKVLHHMVKISGMAGE-A3 281-295
CancerH-2 IAb4117SGHNCGTCRPGWRGAACNQKILTVRTyrosinase-related protein 1 1106-130
CMVDRB1*01:011126LPLKMLNIPSINVHCMV pp65 116-129
CMVDRB1*07:012720EPDVYYTSAFVFPTKCMV pp65 177-191
CMVDRB1*07:012721PDDYSNTHSTRYVTVCMV gB 215-229
CMVDRB1*15:011942MSIYVYALPLKMLNICMV pp65 109-123
COVID-19 / SARS-CoV-2DRB1*01:014407TSRTLSYYKLGASQRVASARS-CoV-2  Membrane glycoprotein 172-188?
COVID-19 / SARS-CoV-2DRB1*01:014683ATRFQTLLALHRSYLTSARS-CoV-2 Spike 236-250
COVID-19 / SARS-CoV-2DRB1*01:014702AFYVYSRVKNLNSSRVSARS-CoV-2 Env 56-70
COVID-19 / SARS-CoV-2DRB1*01:014703ALEASFNYLKSPNFSKSARS-CoV-2 ORF1ab 2211-2225
COVID-19 / SARS-CoV-2DRB1*01:014704ALSYYKLGASQRVAGDSARS-CoV-2 gp 176-190
COVID-19 / SARS-CoV-2DRB1*01:014705ASEFSSLPSYAAFATASARS-CoV-2 ORF1ab 3948-3962
COVID-19 / SARS-CoV-2DRB1*04:014683BTRFQTLLALHRSYLTSARS-CoV-2 Spike 236-250
COVID-19 / SARS-CoV-2DRB1*04:014702BFYVYSRVKNLNSSRVSARS-CoV-2 Env 56-70
COVID-19 / SARS-CoV-2DRB1*04:014703BLEASFNYLKSPNFSKSARS-CoV-2 ORF1ab 2211-2225
COVID-19 / SARS-CoV-2DRB1*04:014704BLSYYKLGASQRVAGDSARS-CoV-2 gp 176-190
COVID-19 / SARS-CoV-2DRB1*04:014705BSEFSSLPSYAAFATASARS-CoV-2 ORF1ab 3948-3962
COVID-19 / SARS-CoV-2DRB1*15:014405NLLLQYGSFCTQLNRSARS-CoV-2 Spike glycoprotein 751-765
COVID-19 / SARS-CoV-2DRB1*15:014406TDEMIAQYTSALLAGSARS-CoV-2 Spike glycoprotein 866-880
COVID-19 / SARS-CoV-2DRB1*15:014414NLLLQYGSFCTQLNRALSARS-CoV-2 Spike glycoprotein 751-767
COVID-19 / SARS-CoV-2DRB1*15:014683CTRFQTLLALHRSYLTSARS-CoV-2 Spike 236-250
COVID-19 / SARS-CoV-2DRB1*15:014702CFYVYSRVKNLNSSRVSARS-CoV-2 Env 56-70
COVID-19 / SARS-CoV-2DRB1*15:014703CLEASFNYLKSPNFSKSARS-CoV-2 ORF1ab 2211-2225
COVID-19 / SARS-CoV-2DRB1*15:014704CLSYYKLGASQRVAGDSARS-CoV-2 gp 176-190
COVID-19 / SARS-CoV-2DRB1*15:014705CSEFSSLPSYAAFATASARS-CoV-2 ORF1ab 3948-3962
COVID-19 / SARS-CoV-2DRB1*01:014329GAALQIPFAMQMAYRFSARS-CoV S protein (873-888) (conserved in SARS-CoV-2)
COVID-19 / SARS-CoV-2DRB1*01:014330MAYRFNGIGVTQNVLYSARS-CoV S protein (884-899) (conserved in SARS-CoV-2)
COVID-19 / SARS-CoV-2DRB1*01:014331AQLIRAAEIRASANLAATKSARS-CoV S protein (993-1010) (conserved in SARS-CoV-2)
COVID-19 / SARS-CoV-2DRB1*03:01464CTFEYVSQPFLMDLESARS-CoV2 Spike Protein (S) 166-180
COVID-19 / SARS-CoV-2DRB1*04:014332QALNTLVKQLSSNFGAISARS-CoV S protein (939-955)(conserved in SARS-CoV-2)
COVID-19 / SARS-CoV-2DRB1*04:014331BQLIRAAEIRASANLAATKSARS-CoV S protein (993-1010) (conserved in SARS-CoV-2)
EBVDRB1*01:011940TVFYNIPPMPLEBV EBNA2 280-290
EBVDRB1*01:012738TSLYNLRRGTALAEBV EBNA1 515-527
EBVDRB1*04:01822PYYVVDLSVRGMEBV BHRF1 122-133
EBVDRB1*04:012702AEGLRALLARSHVEREBV EBNA1 482-496
EBVDRB1*04:012882GQTYHLIVDTDSLGNPSLSVEBV EBNA2 11-30
EBVDRB1*07:012723VPGLYSPCRAFFNKEELLEBV MCP 1264-1281
EBVDRB1*07:012735PGPLRESIVCYFMVFLQTHIEBV EBNA1 551-570
EBVDRB1*07:012883VYGGSKTSLYNLRRGTALAIEBV EBNA1 509-528
EBVDRB1*07:012884PRSPTVFYNIPPMPLPPSQLEBV EBNA2 276-295
Factor VIIIDRB1*11:013140ENIQRFLPNPAGVQLEDPEFFactor VIII 589-608
Factor VIIIDRB1*15:014333TLFFQNGKVKVFQGNQDSFTFactor VIII 2291–2310
Factor VIIIH-2 IAb4118TASSYFTNMFATWSPSKARLHuman clotting factor VIII 2210-2229
HBVDRB1*01:012691QAGFFLLTRILTIPQSHBV envelope 179-194
HBVDRB1*01:012699PPAYRPPNAPILSTLHBV core 158-172
HBVDRB1*01:012739LCWGELMTLATWVGVNHBV core 60-75
HBVDRB1*04:012722LSFLPSDFFPSVRDLHBV core 45-59
HCVDRB1*01:012690TLLFNILGGWVAAHCV polyprotein 1806?1818, NS4b
HCVDRB1*03:012703VYYLTRDPTTPLARAAHCV polyprotein 2800-2815, NS5b
HCVDRB1*04:01549GYKVLVLNPSVAATLHCV polyprotein 1248-1262, NS3
HCVDRB1*04:012693SGIQYLAGLSTLPGNPAIASLHCV polyprotein 1770-1790, NS4b
HCVDRB1*07:013135AYCLWMMLLISQAEAALELITHCV NS2 732-753
HCVDRB1*07:013166WPLLLLLLALPQRAYAQHCV NS2 47-63
HCVDRB1*07:014295SLTITSLLRRHNWITSCSHCV NS5a 1957-1975
HCVDRB1*07:014294ATTVRLRAYMNTPGLPVCHCV NS3 1535-1551
HCVDRB1*15:012715NFPYLVAYQATVCARAHCV polyprotein 1582-1597, NS3
HCVDRB1*15:012727GINAVAYYRGLDVSVHCV polyprotein 1411-1425, NS3
HCVDRB1*15:014294BTTVRLRAYMNTPGLPVCHCV NS3 1535-1551
Helicobacter pyloriH-2 IAb4119GNAYISVLAHYGKNGHelicobacter hepaticus HH1713 230-244
HIVDRB1*01:012741DYVDRFYKTLRAEHIV-1 gag 295-307
HIVDRB1*01:012742KRWIILGLNKIVRMYSPTSIHIV-1 gag 263-282
HIVDRB1*01:012718AFRDYVDRFYKTLRAEQASQEHIV-1 gag 293-312
HIVDRB1*04:012706AFSPEVIPMFSALSEGATPQHIV-1 gag 163-182
HIVDRB1*07:012718BFRDYVDRFYKTLRAEQASQEHIV-1 gag 293-312
HIVDRB1*11:012718CFRDYVDRFYKTLRAEQASQEHIV-1 gag 293-312
HPVDRB1*03:012737PIVQLQGDSNCLKCFRHPV E2 285-300
HPVDRB1*03:013155MEAIAKRLDACQDQLLELYEHPV E2 1-20
InfluenzaDRB1*01:012717SGPLKAEIAQRLEDVInfluenza A MP 17-31
InfluenzaDRB1*01:01357APKYVKQNTLKLATInfluenza A HA 307-319
InfluenzaDRB1*04:012705FWRGENGRKTRIAYERMCNILKGKInfluenza A NP 206-229
InfluenzaDRB1*04:012729GFVFTLTVPSERInfluenza A MP 61-72
InfluenzaDRB1*04:01357BPKYVKQNTLKLATInfluenza A HA 307-319
InfluenzaDRB1*04:02357FPKYVKQNTLKLATInfluenza A HA 307-319
InfluenzaDRB1*04:05357EPKYVKQNTLKLATInfluenza A HA 307-319
InfluenzaDRB1*07:01357CPKYVKQNTLKLATInfluenza A HA 307-319
InfluenzaDRB1*11:01357DPKYVKQNTLKLATInfluenza A HA 307-319
InfluenzaH-2 IAb3029QVYSLIRPNENPAHKInfluenza A nucleocapsid protein 311-325
InfluenzaH-2 IAd4268HNTNGVTAACSHEIAd Influenza A HA 143-155
InfluenzaH-2 IAd4269RGHNVNGVTAACSHEIAd Influenza A HA 141-155
InfluenzaH-2 IAd4270SLLTEVETPIRNEWGSIAd Influenza A M2 2-17
LCMVH-2 IAb3023DIYKGVYQFKSVLymphocytic choriomeningitis virus glycoprotein 66-77
LCMVH-2 IAb4122TMFEALPHIIDEVINLymphocytic choriomeningitis virus glycoprotein 6-20
LCMVH-2 IAd4123CDMLRLIDYNKAALSLymphocytic choriomeningitis virus glycoprotein 316-330
LCMVH-2 IAd4124PSLTMACMAKQSQTPLymphocytic choriomeningitis virus nucleoprotein 176-190
LCMVH-2 IAd4125SQNRKDIKLIDVEMTLymphocytic choriomeningitis virus nucleoprotein 466-480
LCMVH-2 IAd4271KNVLKVGRLSAEELMIAd LCMV NP 86-100
LCMVH-2 IAd4272SERPQASGVYMGNLTIAd LCMV NP 116-130 (P8)
ListeriaH-2 IAb3028NEKYAQAYPNVSListeriolysin O precursor 190-201
MalariaDRB1*01:012896AEYLNKIQNSLSTEWSPCSVTCSP 326-345
MalariaDRB1*04:012896BEYLNKIQNSLSTEWSPCSVTCSP 326-345
MalariaDRB1*07:012896CEYLNKIQNSLSTEWSPCSVTCSP 326-345
Model Antigens / OtherH-2 IAb1010ISQAVHAAHAEINEAGRChicken ovalbumin 323-339
Model Antigens / OtherH-2 IAb3024EAWGALANWAVDSAI-E alpha chain (2W1S) 52-68
Model Antigens / OtherH-2 IAb3223BAAHAEINEAChicken ovalbumin 329-337
Model Antigens / OtherH-2 IAd3223AAAHAEINEAChicken ovalbumin 329-337
Model Antigens / OtherH-2 IAg74894AHHPIWARMDAMimotope of Chain A, Histocompatibility Antigen I-Ag7 from Mus Musculus Chain A.
Multiple SclerosisDRB1*03:013159RQIFGDYKTTICPLP 98-109
Multiple SclerosisDRB1*04:012963RTELLKDAIGEGKMOG 97-109
Multiple SclerosisDRB1*04:013162TWTTCQSIAFPSKTSASIGSPLP 180-199
Multiple SclerosisH-2 IAb2958GWYRSPFSRVVHMouse myelin oligodendrocyte glycoprotein 38-49
Multiple SclerosisH-2 IAb4131TTHYGSLPQKSQMouse MBP 63-74
Multiple SclerosisH-2 IAb4186GWYRPPFSRVVHMOG 38-49 var S42P
Multiple SclerosisH-2 IAb4187GWYRSPFSRAVHMOG 38-49 var V47A
Negative Control / CLIPDRB1*01:01N02APVSKMRMATPLLMQACLIP 87-101
Negative Control / CLIPDRB1*03:01N02BPVSKMRMATPLLMQACLIP 87-101
Negative Control / CLIPDRB1*04:01N02CPVSKMRMATPLLMQACLIP 87-101
Negative Control / CLIPDRB1*04:02N02IPVSKMRMATPLLMQACLIP 87-101
Negative Control / CLIPDRB1*04:05N02HPVSKMRMATPLLMQACLIP 87-101
Negative Control / CLIPDRB1*07:01N02DPVSKMRMATPLLMQACLIP 87-101
Negative Control / CLIPDRB1*09:01N02GPVSKMRMATPLLMQACLIP 87-101
Negative Control / CLIPDRB1*11:01N02EPVSKMRMATPLLMQACLIP 87-101
Negative Control / CLIPDRB1*15:01N02FPVSKMRMATPLLMQACLIP 87-101
Negative Control / CLIPH-2 IAbN02JPVSQMRMATPLLMRPMurine class II-associated invariant chain peptide (CLIP) 86-100
Negative Control / CLIPH-2 IAbN02KPVSKMRMATPLLMQAHuman class II-associated invariant chain peptide (CLIP) 103-117
Negative Control / CLIPH-2 IAdN02MPVSQMRMATPLLMRPMurine class II-associated invariant chain peptide (CLIP) 86-100
Negative Control / CLIPH-2 IAg7N02LPVSQMRMATPLLMRPMurine class II-associated invariant chain peptide (CLIP) 86-100
RSVH-2 IAb4132NKGAFKYIKPQSQFIRespiratory syncytial virus matrix protein M 209-223
RSVH-2 IAb4133NYFEWPPHALLVRQRespiratory syncytial virus matrix protein 2 26-39
TetanusDRB1*01:013158QEIYMQHTYPISATT 257-269
TetanusDRB1*11:012716VSIDKFRIFCKALNPKTT 1084-1099
TetanusDRB1*11:012719FNNFTVSFWLRVPKVSASHLETT 947-967
TetanusDRB1*11:012728KFIIKRYTPNNEIDSFTT 1174-1189
TetanusDRB1*11:012740QYIKANSKFIGITELTT 830-844
Therapeutic AntibodiesDRB1*04:013243ASSPKPWIYATSNLASRituximab Light chain 41-55
Therapeutic AntibodiesDRB1*07:013242AWVKQTPGRGLEWIGARituximab Heavy chain 36-50
Therapeutic AntibodiesDRB1*07:013243BSSPKPWIYATSNLASRituximab Light chain 41-55
Therapeutic AntibodiesDRB1*07:013244AEWVAEIRSKSINSATInfliximab Heavy chain 46-60
Therapeutic AntibodiesDRB1*11:013242BWVKQTPGRGLEWIGARituximab Heavy chain 36-50
Therapeutic AntibodiesDRB1*15:013243CSSPKPWIYATSNLASRituximab Light chain 41-55
Therapeutic AntibodiesDRB1*15:013244BEWVAEIRSKSINSATInfliximab Heavy chain 46-60
TuberculosisDRA1*04:014250EISTNIRQAGVQYSRM. tuberculosis CFP-10 71-85
TuberculosisDRB1*01:012902GEEYLILSARDVLAVMtb 10 kDa chaperonin GroES
TuberculosisDRB1*03:013115MAKTIAYDEEARRMtb groEL 1-13
TuberculosisDRB1*03:013149KTIAYDEEARRMtb groEL 3-13
TuberculosisDRB1*09:013156MTEQQWNFAGIEAAAMtb ESAT6 1-15
TuberculosisDRB1*15:012900MHVSFVMAYPEMLAAMtb PE family protein
TuberculosisDRB1*15:012901MSQIMYNYPAMMAHAMtb ESAT-6 like protein
TuberculosisH-2 IAb3027FQDAYNAAGGHNAVFM. tuberculosis antigen 85B precursor 280-294
TuberculosisH-2 IAb4135KAAGLFNAPASQLARM. tuberculosis RplJ 140-164
TuberculosisH-2 IAb4136MTEQQWNFAGIEAAASAIQGESAT-6
West Nile VirusH-2 IAb4137PVGRLVTVNPFVSVAWest Nile Virus envelope protein 641-655

(back to top)

© Copyright ProImmune Ltd. 2001-2024. All Rights Reserved